Side-by-side comparison of AI visibility scores, market position, and capabilities
Boston industrial CAD/PLM software (NASDAQ: PTC); FY2025 8.5% ARR growth, Kepware/ThingWorx IoT divested to TPG (Nov 2025) under new CEO Neil Barua competing with Siemens Teamcenter for discrete manufacturer PLM.
PTC Inc. is a Boston, Massachusetts-based industrial software company — publicly traded on NASDAQ (NASDAQ: PTC) as an S&P 500 component — providing computer-aided design (CAD), product lifecycle management (PLM), application lifecycle management (ALM), service lifecycle management (SLM), and industrial IoT software to manufacturers across aerospace, defense, automotive, medical devices, and industrial machinery. In FY2025 (fiscal year ended September 30, 2025), PTC reported 8.5% ARR growth and 16% free cash flow growth, with Q4 FY2025 revenue up 39% in constant currency and 18% year-over-year. CEO Neil Barua took over from long-tenured CEO James Heppelmann in February 2024 and introduced the "Barua Blueprint" refocusing PTC on its core CAD/PLM/ALM/SLM strengths. In November 2025, PTC announced the divestiture of its industrial IoT assets — Kepware and ThingWorx — to TPG, sharpening its portfolio around design and lifecycle management software. PTC's product portfolio includes Creo (3D parametric CAD for mechanical engineers), Windchill (PLM for product data and process management), Onshape (cloud-native CAD platform), and Arena (cloud-native PLM/QMS).
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.